Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lipitor

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lipitor was produced by Pfizer and Astellas.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era

autonomous. Created in the summer reshuffle, the Established Medicines division includes the majority of Pfizer’s off-patent blockbuster pills, including Lyrica, Lipitor, Norvasc and Viagra, and a number of other

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires Ian Read’s tenure has had plenty of ups and downs, and undoubtedly one of his biggest challenges was overcoming the patent expiry of its mega-blockbuster Lipitor in November 2011. ... Pfizer slipped down the rankings in the years following the loss of

Using social data to see patients more clearly

Using social data to see patients more clearly Drugs and databases analysed. The study focused on two drugs, aspirin and Lipitor, that had a relatively high prevalence among the ADR reports in both the clinical and the social media ... In both data sets, musculoskeletal pain and cramps were among the

Pharma set for a strong 2015 as drug sales jump

Pharma set for a strong 2015 as drug sales jump Pfizer was in fact the hardest hit, with its once $13bn a year statin Lipitor (atorvastatin) losing its patents in 2011/12, with sales falling by $10bn in just two years.

Pfizer maintains lead in top CNS drug sales - just

Pfizer maintains lead in top CNS drug sales - just It is also now Pfizer's top-selling medicine after the 2012 patent expiry of its once £13bn a year statin Lipitor (atorvastatin).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics